The dietary flavonoid kaempferol mediates anti-inflammatory responses via the src, syk, IRAK1, and IRAK4 molecular targets

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Kim, Shi Hyoung ^a   Park, Jae Gwang ^a   Lee, Jongsung ^b   Yang, Woo Seok ^a   Park, Gye Won ^a   Kim, Han Gyung ^a   Yi, Young Su ^a   Baek, Kwang Soo ^a   Sung, Nak Yoon ^a   Hossen, Muhammad Jahangir ^a,c   Lee, Mi Nam ^d   Kim, Jong Hoon ^e   Cho, Jae Youl ^a  

^a Sungkyunkwan University   (South Korea)

^b Eulji University   (South Korea)

^c PATUAKHALI SCIENCE AND TECHNOLOGY UNIVERSITY   (Bangladesh)

^d Chungkang College of Cultural Industries   (South Korea)

^e Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; KAEMPFEROL; LUCIFERASE; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN C FOS; PROTEIN C JUN; PROTEIN KINASE P60; PROTEIN KINASE SYK; PROTEIN P50; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, HUMAN; IRAK1 PROTEIN, MOUSE; IRAK4 PROTEIN, HUMAN; IRAK4 PROTEIN, MOUSE; KAEMPFEROL DERIVATIVE; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SYK PROTEIN, HUMAN; SYK PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CELL ACTIVITY; CELL ADHESION; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; U937 CELL LINE; ANIMAL; C57BL MOUSE; CELL NUCLEUS; CHEMISTRY; METABOLISM; PHOSPHORYLATION; U-937 CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL NUCLEUS; FIBRONECTINS; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAEMPFEROLS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SYK KINASE; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 84928242572     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/904142     Document Type: Article

References (65)

1. D. W. Hommes and S. J. H. Van Deventer, "Anti-and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 3, no. 3, pp. 191-195, 2000.
2. Y. S. Yi, Y. J. Son, C. Ryou, G. H. Sung, J. H. Kim, and J. Y. Cho, "Functional roles of syk inmacrophage-mediated inflammatory responses," Mediators of Inflammation, vol. 2014, Article ID 270302, 12 pages, 2014.
3. M.-Y. Kim and J. Y. Cho, "20S-dihydroprotopanaxadiol, a ginsenoside derivative, boosts innate immune responses of monocytes and macrophages," Journal of Ginseng Research, vol. 37, no. 3, pp. 293-299, 2013.
4. M. B. Richardson and S. J. Williams, "MCL and mincle: Ctype lectin receptors that sense damaged self and pathogenassociated molecular patterns," Frontiers in Immunology, vol. 5, article 288, 2014.
5. T. Yu, Y. J. Li, A. H. Bian et al., "The regulatory role of activating transcription factor 2 in inflammation," Mediators of Inflammation, vol. 2014,Article ID 950472, 10 pages, 2014.
6. Y. Kobayashi, A. Iwata, K. Suzuki et al., "B and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 13, pp. 5121-5126, 2013.
7. T. Romacho, C. F. Sánchez-Ferrer, and C. Peiró, "Visfatin/ Nampt: an adipokine with cardiovascular impact," Mediators of Inflammation, vol. 2013,Article ID 946427, 15 pages, 2013.
8. J. Hofmanová,N. Straková, A. H. Vaculová et al., "Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer," Mediators of Inflammation, vol. 2014,Article ID 848632, 17 pages, 2014.
9. E. Barreiro, C. Fermoselle, M. Mateu-Jimenez et al., "Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD," Free Radical Biology and Medicine, vol. 65, pp. 859-871, 2013.
10. A. Morales-Sánchez and E. M. Fuentes-Pananá, "Human viruses and cancer," Viruses, vol. 6, no. 10, pp. 4047-4079, 2014.
11. A. B. Porcaro, E. Rubilotta, A. Petrozziello et al., "Chronic inflammation of the prostate type IV with respect to risk of prostate cancer," Archivio Italiano di Urologia e Andrologia, vol. 86, no. 3, pp. 208-211, 2014.
12. J. M. Calderon-Montano, E. Burgos-Moron, C. Perez-Guerrero, and M. Lopez-Lazaro, "A review on the dietary flavonoid kaempferol," Mini-Reviews in Medicinal Chemistry, vol. 11, no. 4, pp. 298-344, 2011.
13. A. Y. Chen and Y. C. Chen, "A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention," Food Chemistry, vol. 138, no. 4, pp. 2099-2107, 2013.
14. G. Williamson and A. Carughi, "Polyphenol content and health benefits of raisins," Nutrition Research, vol. 30,no. 8, pp. 511-519, 2010.
15. H. Y. Jeong, G.-H. Sung, J. H. Kimet al., "Syk and Src are major pharmacological targets of a Cerberamanghas methanol extract with kaempferol-based anti-inflammatory activity," Journal of Ethnopharmacology, vol. 151, no. 2, pp. 960-969, 2014.
16. P. Rajendran, T. Rengarajan, N. Nandakumar, R. Palaniswami, Y. Nishigaki, and I. Nishigaki, "Kaempferol, a potential cytostatic and cure for inflammatory disorders," European Journal of Medicinal Chemistry, vol. 86, pp. 103-112, 2014.
17. S. S. Chen, A. Michael, and S. A. Butler-Manuel, "Advances in the treatment of ovarian cancer: a potential role of antiinflammatory phytochemicals," Discovery Medicine, vol. 13, no. 68, pp. 7-17, 2012.
18. S. V. Jovanovic and M. G. Simic, "Antioxidants in nutrition," Annals of the New York Academy of Sciences, vol. 899, pp. 326-334, 2000.
19. K. Yao, H. Chen, K. Liu et al., "Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer," Cancer Prevention Research, vol. 7, no. 9, pp. 958-967, 2014.
20. H. Wang, M. Gao, and J. Wang, "Kaempferol inhibits cancer cell growth by antagonizing estrogen-related receptor and activities," Cell Biology International, vol. 37, no. 11, pp. 1190-1196, 2013.
21. K. M. Lee, D. E. Lee, S. K. Seo et al., "Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation," Carcinogenesis, vol. 31, no. 8, pp. 1338-1343, 2010.
22. M. J. Park, E. K. Lee, H.-S. Heo et al., "The anti-inflammatory effect of kaempferol in aged kidney tissues: the involvement of nuclear factor-B via nuclear factor-inducing kinase/IB kinase andmitogen-activated protein kinase pathways," Journal of Medicinal Food, vol. 12, no. 2, pp. 351-358, 2009.
23. X. Chen, X. Yang, T. Liu et al., "Kaempferol regulates MAPKs and NF-B signaling pathways to attenuate LPS-induced acute lung injury in mice," International Immunopharmacology, vol. 14, no. 2, pp. 209-216, 2012.
24. H. K. Kim,H. R. Park, J. S. Lee, T. S. Chung, H. Y. Chung, and J. Chung, "Down-regulation of iNOS and TNF-expression by kaempferol via NF-B inactivation in aged rat gingival tissues," Biogerontology, vol. 8, no. 4, pp. 399-408, 2007.
25. A. R. Kim, J. Y. Cho, Y. Zou, J. S. Choi, and H. Y. Chung, "Flavonoids differentially modulate nitric oxide production pathways in lipopolysaccharide-activated RAW264. 7 cells," Archives of Pharmacal Research, vol. 28,no. 3, pp. 297-304, 2005.
26. H.-J. Chen, C.-M. Lin, C.-Y. Lee et al., "Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells," Oncology Reports, vol. 30, no. 2, pp. 925-932, 2013.
27. K.-J. Yang, S. Shin, L. Piao et al., "Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding," The Journal of Biological Chemistry, vol. 283, no. 3, pp. 1480-1491, 2008.
28. T. Shen, W. S. Yang, Y.-S. Yi et al., "AP-1/IRF-3 targeted anti-inflammatory activity of andrographolide isolated from Andrographis paniculata," Evidence-Based Complementary and AlternativeMedicine, vol. 2013, Article ID210736, 16 pages, 2013.
29. E.-H. Joh, J.-J. Jeong, and D.-H. Kim, "Inhibitory effect of echinocystic acid on 12-O-tetradecanoylphorbol-13-acetateinduced dermatitis in mice," Archives of Pharmacal Research, vol. 37, no. 2, pp. 225-231, 2014.
30. D. H. Kim, J. H. Chung, J. S. Yoon et al., "Ginsenoside Rd inhibits the expressions of iNOS andCOX-2 by suppressingNF-B in LPS-stimulated RAW264. 7 cells and mouse liver," Journal of Ginseng Research, vol. 37, no. 1, pp. 54-63, 2013.
31. C. K. Youn, S. J. Park, M. Y. Lee et al., "Silibinin inhibits LPSinducedmacrophage activation by blocking p38MAPKinRAW 264. 7 cells," Biomolecules and Therapeutics, vol. 21, no. 4, pp. 258-263, 2013.
32. J. Y. Cho,D. A. Fox,V. Horejsi et al., "Thefunctional interactions between CD98, 1-integrins, and CD147 in the induction of U937 homotypic aggregation," Blood, vol. 98,no. 2, pp. 374-382, 2001.
33. M.-Y. Kim and J. Y. Cho, "20S-dihydroprotopanaxatriol modulates functional activation of monocytes and macrophages," Journal of Ginseng Research, vol. 37, no. 3, pp. 300-307, 2013.
34. S. Larrucea, C. González-Rubio, R. Cambronero et al., "Cellular adhesion mediated by factor J, a complement inhibitor: evidence for nucleolin involvement," The Journal of Biological Chemistry, vol. 273, no. 48, pp. 31718-31725, 1999.
35. Y. G. Lee, W. M. Lee, J. Y. Kim et al., "Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activated RAW264. 7 cells," British Journal of Pharmacology, vol. 154, no. 4, pp. 852-863, 2008.
36. R. Pauwels, J. Balzarini, M. Baba et al., "Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds," Journal of Virological Methods, vol. 20, no. 4, pp. 309-321, 1988.
37. T. Yayeh, K.-H. Jung, H. Y. Jeong et al., "Korean red ginseng saponin fraction downregulates proinflammatory mediators in LPS stimulated RAW264. 7 cells and protects mice against endotoxic shock," Journal of Ginseng Research, vol. 36, no. 3, pp. 263-269, 2012.
38. C. T. Oh, J. I. Park, Y. R. Jung et al., "Inhibitory effect of Korean Red Ginseng on melanocyte proliferation and its possible implication in GM-CSF mediated signaling," Journal of Ginseng Research, vol. 37, no. 4, pp. 389-400, 2013.
39. Y. G. Lee, B. M. Chain, and J. Y. Cho, "Distinct role of spleen tyrosine kinase in the early phosphorylation of inhibitor of B via activation of the phosphoinositide-3-kinase and Akt pathways," International Journal of Biochemistry and Cell Biology, vol. 41, no. 4, pp. 811-821, 2009.
40. R. Zhang, J. Zhu, H.-Z. Cao et al., "Isolation and characterization of LHT-type plant amino acid transporter gene from Panax ginseng Meyer," Journal of Ginseng Research, vol. 37, no. 3, pp. 361-370, 2013.
41. G.-J. Kang, S.-C. Han, J.-W. Ock, H.-K. Kang, and E.-S. Yoo, "Anti-inflammatory effect of quercetagetin, an active component of immature Citrus unshiu, in HaCaT human keratinocytes," Biomolecules andTherapeutics, vol. 21, no. 2, pp. 138-145, 2013.
42. S. E. Byeon, Y. G. Lee, B. H. Kim et al., "Surfactin blocks NO production in lipopolysaccharide-activated macrophages by inhibiting NF-kappaB activation," Journal of Microbiology and Biotechnology, vol. 18, no. 12, pp. 1984-1989, 2008.
43. J.-A. Lee, M.-Y. Lee, I.-S. Shin, C.-S. Seo, H. Ha, and H. K. Shin, "Anti-inflammatory effects of amomum compactum on RAW 264. 7 cells via induction of heme oxygenase-1," Archives of Pharmacal Research, vol. 35, no. 4, pp. 739-746, 2012.
44. T. Shen, J. Lee,M. H. Park et al., "GinsenosideRp1, a ginsenoside derivative, blocks promoter activation of iNOS and Cox-2 genes by suppression of an IKK-mediated NF-B pathway in HEK293 cells," Journal of Ginseng Research, vol. 35, no. 2, pp. 200-208, 2011.
45. S. B. Song, N. H. Tung, T. H. Quang, N. T. T. Ngan, K. E. Kim, and Y. H. Kim, "Inhibition of TNF-mediated NF-B transcriptional activity in HepG2 cells by dammaranetype saponins from Panax ginseng leaves," Journal of Ginseng Research, vol. 36, no. 2, pp. 146-152, 2012.
46. K. K. Jung, H. S. Lee, J. Y. Cho et al., "Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharideactivated primary microglia," Life Sciences, vol. 79, no. 21, pp. 2022-2031, 2006.
47. D. Jeong, Y.-S. Yi, G.-H. Sung et al., "Anti-inflammatory activities andmechanisms ofArtemisia asiatica ethanol extract," Journal of Ethnopharmacology, vol. 152, no. 3, pp. 487-496, 2014.
48. J. Y. Lee, Y. G. Lee, J. Lee et al., "Akt Cys-310-targeted inhibition by hydroxylated benzene derivatives is tightly linked to their immunosuppressive effects," The Journal of Biological Chemistry, vol. 285, no. 13, pp. 9932-9948, 2010.
49. S. E. Byeon, Y.-S. Yi, J. Oh, B. C. Yoo, S. Hong, and J. Y. Cho, "The role of Src kinase in macrophage-mediated inflammatory responses," Mediators of Inflammation, vol. 2012, Article ID 512926, 18 pages, 2012.
50. S. E. Byeon, T. Yu, Y. Yang et al., "Hydroquinone regulates hemeoxygenase-1 expression via modulation of Src kinase activity through thiolation of cysteine residues," Free Radical Biology and Medicine, vol. 57, pp. 105-118, 2013.
51. J. Brown, H. Wang, G. N. Hajishengallis, and M. Martin, "TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk," Journal of Dental Research, vol. 90, no. 4, pp. 417-427, 2011.
52. I.-T. Lee and C.-M. Yang, "Inflammatory signalings involved in airway and pulmonary diseases," Mediators of Inflammation, vol. 2013, Article ID791231, 12 pages, 2013.
53. S. Ravichandran, N. Singh, D. Donnelly et al., "Pharmacophore model of the quercetin binding site of the SIRT6 protein," Journal ofMolecular Graphics andModelling, vol. 49, pp. 38-46, 2014.
54. S. Nag, K. M. N. Prasad, A. Bhowmick, R. Deshmukh, and V. Trivedi, "PfRIO-2 kinase is a potential therapeutic target of antimalarial protein kinase inhibitors," Current Drug Discovery Technologies, vol. 10, no. 1, pp. 85-91, 2013.
55. N. Aligiannis, S. Mitaku, D. Mitrocotsa, and S. Leclerc, "Flavonoids as cycline-dependent kinase inhibitors: inhibition of cdc 25 phosphatase activity by flavonoids belonging to the quercetin and kaempferol series," Planta Medica, vol. 67, no. 5, pp. 468-470, 2001.
56. L. Thors, M. Belghiti, and C. J. Fowler, "Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids," British Journal of Pharmacology, vol. 155, no. 2, pp. 244-252, 2008.
57. T. Georgakopoulos, S. T. Moss, and V. Kanagasundaram, "Integrin CD11c contributes to monocyte adhesion with CD11b in a differential manner and requires Src family kinase activity," Molecular Immunology, vol. 45, no. 13, pp. 3671-3681, 2008.
58. M. Riva, E. Källberg, P. Björk et al., "Induction of nuclear factor-B responses by the S100A9 protein is Toll-like receptor-4-dependent," Immunology, vol. 137, no. 2, pp. 172-182, 2012.
59. C. Jin and R. A. Flavell, "Innate sensors of pathogen and stress: linking inflammation to obesity," Journal of Allergy and Clinical Immunology, vol. 132, no. 2, pp. 287-294, 2013.
60. S. H. Park, E. Roh, H. S. Kim et al., "Inhibition of IRAK-4 activity for rescuing endotoxin LPS-induced septic mortality in mice by lonicerae flos extract," Biochemical and Biophysical Research Communications, vol. 442, no. 3-4, pp. 183-188, 2013.
61. T. Piegeler, R. O. Dull, G. Hu et al., "Ropivacaine attenuates endotoxin plus hyperinflation-mediated acute lung injury via inhibition of early-onset Src-dependent signaling," BMC Anesthesiology, vol. 14, article 57, 2014.
62. M. Brenner and P. S. Gulko, "The arthritis severity locus Cia5a regulates the expression of inflammatory mediators including Syk pathway genes and proteases in pristane-induced arthritis," BMC Genomics, vol. 13, no. 1, article 710, 2012.
63. G. Lolli, G. Cozza, M. Mazzorana et al., "Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight," Biochemistry, vol. 51, no. 31, pp. 6097-6107, 2012.
64. D. W. Gilroy and M. Perretti, "Aspirin and steroids: new mechanistic findings and avenues for drug discovery," Current Opinion in Pharmacology, vol. 5, no. 4, pp. 405-411, 2005.
65. H. J. Kim, P. Kim, and C. Y. Shin, "A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system," Journal of Ginseng Research, vol. 37, no. 1, pp. 8-29, 2013.